Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | September 04, 2024

Preparing Your Company for Hatch-Waxman

Blog | August 16, 2024

Texas Patent Litigation Monthly Wrap-Up: July 2024

Blog | August 15, 2024

Texas Patent Litigation Monthly Wrap-Up: June 2024

Blog | July 30, 2024

How the Timing of Director Review May Affect Co-Pending Litigation

Blog | July 11, 2024

Five Tactics for Cybersecurity Companies to Defeat Patent Infringement Claims

Blog | June 14, 2024

Texas Patent Litigation Monthly Wrap-Up: May 2024

Blog | May 09, 2024

Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis

Blog | May 01, 2024

Legal Alert: What the FTC’s Ban on Noncompete Agreements Means for Trade Secrets

Blog | April 15, 2024

Hatch-Waxman 101

Blog | April 05, 2024

Biologics and Biosimilars Landscape 2023: IP, Policy, and Market Developments

Blog | March 12, 2024

ITC Monthly Wrap-Up: February 2024

Blog | February 12, 2024

ITC Monthly Wrap-Up: January 2024